Literature DB >> 1987606

Normal and abnormal pituitary glands: gadopentetate dimeglumine-enhanced MR imaging.

Y Sakamoto1, M Takahashi, Y Korogi, H Bussaka, Y Ushio.   

Abstract

Dynamic magnetic resonance (MR) imaging with a 1.5-T superconductive unit was used in the evaluation of nine normal pituitary glands and 10 pituitary adenomas, including four microadenomas and six macroadenomas. Seven to 10 images were obtained every 20-30 seconds with use of the spin-echo technique after rapid injection of gadopentetate dimeglumine. The earliest contrast material enhancement of normal structures was seen in the infundibulum and posterior lobe of the pituitary gland at 20 seconds, followed by gradual contrast material enhancement of the anterior lobe of the pituitary gland from the junction of the infundibulum to the peripheral portion of the anterior lobe of the pituitary gland within 80 seconds after gadopentetate dimeglumine injection. The peak enhancement of pituitary adenomas occurred at 60-200 seconds, usually after the most marked enhancement of the normal pituitary gland. Microadenomas are best visualized at earlier phases of gadopentetate dimeglumine-enhanced dynamic imaging, with signal intensity lower than that seen on images of normal pituitary glands.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1987606     DOI: 10.1148/radiology.178.2.1987606

Source DB:  PubMed          Journal:  Radiology        ISSN: 0033-8419            Impact factor:   11.105


  19 in total

1.  Usefulness of the dynamic gadolinium-enhanced magnetic resonance imaging with simultaneous acquisition of coronal and sagittal planes for detection of pituitary microadenomas.

Authors:  Han Bee Lee; Sung Tae Kim; Hyung-Jin Kim; Keon Ha Kim; Pyoung Jeon; Hong Sik Byun; Jin Wook Choi
Journal:  Eur Radiol       Date:  2011-09-24       Impact factor: 5.315

Review 2.  State of art imaging of the pituitary tumors.

Authors:  Nicholas J Patronas; Chia-Ying Liu
Journal:  J Neurooncol       Date:  2013-12-17       Impact factor: 4.130

3.  Evaluation of diffusivity in the anterior lobe of the pituitary gland: 3D turbo field echo with diffusion-sensitized driven-equilibrium preparation.

Authors:  A Hiwatashi; T Yoshiura; O Togao; K Yamashita; K Kikuchi; K Kobayashi; M Ohga; S Sonoda; H Honda; M Obara
Journal:  AJNR Am J Neuroradiol       Date:  2013-07-18       Impact factor: 3.825

4.  Brain-endocrine interactions: a microvascular route in the mediobasal hypothalamus.

Authors:  Philippe Ciofi; Maurice Garret; Olivier Lapirot; Pierrette Lafon; Anne Loyens; Vincent Prévot; Jon E Levine
Journal:  Endocrinology       Date:  2009-10-16       Impact factor: 4.736

5.  Intrasellar meningioma: characteristic imaging findings.

Authors:  H Satoh; K Arita; K Kurisu; M Sumida; T Nakahara; K Eguchi; K Kuroki
Journal:  Neuroradiology       Date:  1996-05       Impact factor: 2.804

6.  Intraoperative multiple-staged resection and tumor tissue identification using frozen sections provide the best result for the accurate localization and complete resection of tumors in Cushing's disease.

Authors:  Jung Soo Lim; Seung Ku Lee; Se Hoon Kim; Eun Jig Lee; Sun Ho Kim
Journal:  Endocrine       Date:  2011-06-19       Impact factor: 3.633

7.  MRI of pituitary hyperplasia in hypothyroidism.

Authors:  L J Wolansky; G D Leavitt; B J Elias; H J Lee; A Dasmahapatra; W Byrne
Journal:  Neuroradiology       Date:  1996-01       Impact factor: 2.804

8.  Sequential contrast-enhanced magnetic resonance imaging in the diagnosis of growth hormone deficiencies.

Authors:  A Liotta; C Maggio; M Giuffrè; M Carta; L Manfrè
Journal:  J Endocrinol Invest       Date:  1999-11       Impact factor: 4.256

9.  Dynamic enhancement MRI of anterior lobe in pituitary dwarfism.

Authors:  H M Liu; Y W Li; W Y Tsai; C T Su
Journal:  Neuroradiology       Date:  1995-08       Impact factor: 2.804

10.  MRI of an unenhancing tuberculum sellae meningioma.

Authors:  M Sintini; M Frattarelli; L Mavilla
Journal:  Neuroradiology       Date:  1993       Impact factor: 2.804

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.